Missing the Mark - Hepatic Encephalopathy
Overview
Hepatic encephalopathy (HE) is a major complication and a frequent cause of both initial hospitalization and readmission in cirrhotic patients. It can be difficult to diagnose, as there are no distinctive disease biomarkers, and diagnosis must be made by excluding other causes of neurologic and psychiatric dysfunction.
This CME opportunity features both a podcast series and related journal articles. You’ll learn from gastroenterologists, hepatologists, advanced practice providers, and other critical patient care team members as they address hepatic encephalopathy diagnosis and management practice gaps.
Journal CME activities
Explore the related articles provided below and earn more CME credit:
- Current and Emerging Treatment Modalities
- Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy
- Inadequate Practices for Hepatic Encephalopathy Management in the Inpatient Setting
- Missed Diagnosis of Cirrhosis in the Inpatient Setting
- Hepatic Encephalopathy and Strategies to Prevent Readmission from Inadequate Transitions of Care
- Specific Challenges in Geriatric Cirrhosis and Hepatic Encephalopathy
Learning objectives
Upon completing the podcast series and the associated journal modules, learners will be able to:
- Discuss the changing epidemiology of cirrhosis and undiagnosed cirrhosis for patients with liver disease.
- Assess guidelines and best practices for HE diagnosis and management.
- Develop transition of care plans with patients, caretakers, and specialty providers after an initial HE diagnosis.
Key dates
- Released date:
- May 15, 2025
- Expiration date:
- Jun 1, 2026
Partnership and sponsorship statement
This educational program was developed in collaboration with the Society for Hospital Medicine and was supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC.
Agenda
All times are Eastern.
Session Heading 1: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Session Heading 2: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Course contents
Welcome to Missing the Mark - Hepatic Encephalopathy Podcast Series
Current and Emerging Treatment Modalities
Pretest
Podcast
33 minsPostest
Evaluation
Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy
Pretest
Podcast
30 minsPosttest
Evaluation
Inadequate Practices for Hepatic Encephalopathy Management in the Inpatient Setting
Pretest
Podcast
24 minsPosttest
Evaluation
Missed diagnosis of cirrhosis in the inpatient setting
Pretest
Podcast
20 minsPosttest
Evaluation
Hepatic Encephalopathy and Strategies to Prevent Readmission from Inadequate Transitions of Care
Pretest
Podcast
19 minsPostest
Evaluation
Specific Challenges in Geriatric Cirrhosis and Hepatic Encephalopathy
Pretest
Podcast
41 minsPosttest
Evaluation
Credit information
- CME Expiration Date:
- Jun 01, 2026
Accreditation Statement
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AGA Institute designates this this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, all faculty and planning partners must disclose all their financial relationships with ineligible companies held within the past 24 months. The AGA Institute implements a mechanism to identify and mitigate all conflicts of interest prior to delivering the educational activity to learners.
Resources
Episode details
Financial disclosures (pdf)